Letter to the Editor: Treatment of Covid-19 with Fisetin flavonoid nanoparticles
A novel coronavirus 2019 (Covid-19) was identified in Wuhan, China causing an outbreak of pneumonia worldwide. The first infection of the coronavirus was associated with a kind of seafood. The patient of the covid-19 pandemic was accompanied by the most common symptoms of fever, lung inflammation, dry cough, and tiredness. Researchers have found that natural flavonoid and antioxidant products such as wildly phytomedicine and anti-inflammatory drugs can play a therapeutically rolls in accelerating the recovery of the viral disease. Fisetin, a known flavonoid in fruits and vegetables, is a powerful anti-inflammatory and antioxidant. With the help of drug delivery technology, fisetin can be present in nanoparticles in a targeted manner in a short time with the minimum dose and also the least side effects to create a high degree of effectiveness in the treatment of this virus..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
|---|---|
| Enthalten in: |
Majallah-i ̒Ilmī-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Simnān - 24(2022), 3, Seite 283-287 |
| Sprache: |
Persisch |
|---|
| Beteiligte Personen: |
Seyedeh Sara Azadeh [VerfasserIn] |
|---|
| Links: |
doaj.org [kostenfrei] |
|---|
| Themen: |
Coronavirus |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
DOAJ028991052 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ028991052 | ||
| 003 | DE-627 | ||
| 005 | 20230502210115.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230226s2022 xx |||||o 00| ||per c | ||
| 035 | |a (DE-627)DOAJ028991052 | ||
| 035 | |a (DE-599)DOAJ2bdbfc1b48074ab99ea9e6058075ef37 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a per | ||
| 050 | 0 | |a R5-920 | |
| 100 | 0 | |a Seyedeh Sara Azadeh |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Letter to the Editor: Treatment of Covid-19 with Fisetin flavonoid nanoparticles |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a A novel coronavirus 2019 (Covid-19) was identified in Wuhan, China causing an outbreak of pneumonia worldwide. The first infection of the coronavirus was associated with a kind of seafood. The patient of the covid-19 pandemic was accompanied by the most common symptoms of fever, lung inflammation, dry cough, and tiredness. Researchers have found that natural flavonoid and antioxidant products such as wildly phytomedicine and anti-inflammatory drugs can play a therapeutically rolls in accelerating the recovery of the viral disease. Fisetin, a known flavonoid in fruits and vegetables, is a powerful anti-inflammatory and antioxidant. With the help of drug delivery technology, fisetin can be present in nanoparticles in a targeted manner in a short time with the minimum dose and also the least side effects to create a high degree of effectiveness in the treatment of this virus. | ||
| 650 | 4 | |a coronavirus | |
| 650 | 4 | |a covid-19 | |
| 650 | 4 | |a flavonoids | |
| 650 | 4 | |a fisetin | |
| 650 | 4 | |a nanoparticles | |
| 650 | 4 | |a drug delivery systems | |
| 653 | 0 | |a Medicine | |
| 653 | 0 | |a R | |
| 653 | 0 | |a Medicine (General) | |
| 700 | 0 | |a Narjes Rahmanian |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Majallah-i ̒Ilmī-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Simnān |d Semnan Univeristy of Medical Sciences, 2018 |g 24(2022), 3, Seite 283-287 |w (DE-627)DOAJ000050814 |x 16087046 |7 nnns |
| 773 | 1 | 8 | |g volume:24 |g year:2022 |g number:3 |g pages:283-287 |
| 856 | 4 | 0 | |u https://doaj.org/article/2bdbfc1b48074ab99ea9e6058075ef37 |z kostenfrei |
| 856 | 4 | 0 | |u http://koomeshjournal.semums.ac.ir/article-1-7153-en.html |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1608-7046 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 24 |j 2022 |e 3 |h 283-287 | ||